Your browser doesn't support javascript.
loading
Differences between cardiac troponin I vs. T according to the duration of myocardial ischaemia.
Espinosa, Aaron Shekka; Hussain, Shafaat; Al-Awar, Amin; Jha, Sandeep; Elmahdy, Ahmed; Kalani, Mana; Kakei, Yalda; Zulfaj, Ermir; Aune, Emma; Poller, Angela; Bobbio, Emanuele; Thoirleifsson, Sigurdur; Zeijlon, Rickard; Gudmundursson, Thorstein; Wernbom, Mathias; Lindahl, Bertil; Polte, Christian L; Omerovic, Elmir; Hammarsten, Ola; Redfors, Björn.
Afiliação
  • Espinosa AS; Department of Molecular and Clinical Medicine, Institute of Medicine, University of Gothenburg, Gothenburg 41345, Sweden.
  • Hussain S; Department of Molecular and Clinical Medicine, Institute of Medicine, University of Gothenburg, Gothenburg 41345, Sweden.
  • Al-Awar A; Department of Medical Radiation Sciences, Sahlgrenska Center for Cancer Research, Institute of Clinical Sciences, Sahlgrenska Academy at the University of Gothenburg, Gothenburg 40530, Sweden.
  • Jha S; Department of Molecular and Clinical Medicine, Institute of Medicine, University of Gothenburg, Gothenburg 41345, Sweden.
  • Elmahdy A; Department of Molecular and Clinical Medicine, Institute of Medicine, University of Gothenburg, Gothenburg 41345, Sweden.
  • Kalani M; Department of Molecular and Clinical Medicine, Institute of Medicine, University of Gothenburg, Gothenburg 41345, Sweden.
  • Kakei Y; Department of Molecular and Clinical Medicine, Institute of Medicine, University of Gothenburg, Gothenburg 41345, Sweden.
  • Zulfaj E; Department of Molecular and Clinical Medicine, Institute of Medicine, University of Gothenburg, Gothenburg 41345, Sweden.
  • Aune E; Department of Molecular and Clinical Medicine, Institute of Medicine, University of Gothenburg, Gothenburg 41345, Sweden.
  • Poller A; Department of Molecular and Clinical Medicine, Institute of Medicine, University of Gothenburg, Gothenburg 41345, Sweden.
  • Bobbio E; Department of Molecular and Clinical Medicine, Institute of Medicine, University of Gothenburg, Gothenburg 41345, Sweden.
  • Thoirleifsson S; Department of Molecular and Clinical Medicine, Institute of Medicine, University of Gothenburg, Gothenburg 41345, Sweden.
  • Zeijlon R; Department of Molecular and Clinical Medicine, Institute of Medicine, University of Gothenburg, Gothenburg 41345, Sweden.
  • Gudmundursson T; Department of Molecular and Clinical Medicine, Institute of Medicine, University of Gothenburg, Gothenburg 41345, Sweden.
  • Wernbom M; Department of Health and Rehabilitation, Institute of Neuroscience and Physiology, Sahlgrenska Academy at University of Gothenburg, Gothenburg 40530, Sweden.
  • Lindahl B; Department of Medical Sciences, Uppsala University, Uppsala 75185, Sweden.
  • Polte CL; Department of Molecular and Clinical Medicine, Institute of Medicine, University of Gothenburg, Gothenburg 41345, Sweden.
  • Omerovic E; Department of Molecular and Clinical Medicine, Institute of Medicine, University of Gothenburg, Gothenburg 41345, Sweden.
  • Hammarsten O; Department of Clinical Chemistry, Sahlgrenska University Hospital, Gothenburg 41345, Sweden.
  • Redfors B; Department of Molecular and Clinical Medicine, Institute of Medicine, University of Gothenburg, Gothenburg 41345, Sweden.
Eur Heart J Acute Cardiovasc Care ; 12(6): 355-363, 2023 Jun 02.
Article em En | MEDLINE | ID: mdl-36848390
ABSTRACT

AIMS:

Cardiac troponin T (cTnT) and troponin I (cTnI) are expressed as an obligate 11 complex in the myocardium. However, blood levels of cTnI often rise much higher than that of cTnT in myocardial infarction (MI), whereas cTnT is often higher in patients with stable conditions such as atrial fibrillation. Here we examine high-sensitive (hs) cTnI and hs-cTnT after different durations of experimental cardiac ischaemia. METHODS AND

RESULTS:

hs-cTnI, hs-cTnT, and the hs-cTnT/hs-cTnI ratio were measured in plasma samples from rats before and at 30 and 120 min after 5, 10, 15, and 30 min of myocardial ischaemia. The animals were killed after 120 min of reperfusion, and the infarct volume and volume at risk were measured. hs-cTnI, hs-cTnT, and the hs-cTnT/hs-cTnI ratio were also measured in plasma samples collected from patients with ST-elevation myocardial infarction (STEMI). hs-cTnT and hs-cTnI increased over 10-fold in all rats subjected to ischaemia. The increase of hs-cTnI and hs-cTnT after 30 min was similar, resulting in a hs-cTnI/hs-cTnT ratio around 1. The hs-cTnI/hs-cTnT ratio was also around 1 in blood samples collected at 120 min in rats subjected to 5 or 10 min of ischaemia where no localized necrosis was observed. In contrast, the hs-cTnI/hs-cTnT ratio at 2 h was 3.6-5.5 after longer ischaemia that induced cardiac necrosis. The large hs-cTnI/hs-cTnT ratio was confirmed in patients with anterior STEMI.

CONCLUSION:

Both hs-cTnI and hs-cTnT increased similarly after brief periods of ischaemia that did not cause overt necrosis, whereas the hs-cTnI/hs-cTnT ratio tended to increase following longer ischaemia that induced substantial necrosis. A low hs-cTnI/hs-cTnT ratio around 1 may signify non-necrotic cTn release.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Doença da Artéria Coronariana / Isquemia Miocárdica / Infarto do Miocárdio com Supradesnível do Segmento ST Tipo de estudo: Diagnostic_studies Limite: Animals / Humans Idioma: En Revista: Eur Heart J Acute Cardiovasc Care Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Suécia

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Doença da Artéria Coronariana / Isquemia Miocárdica / Infarto do Miocárdio com Supradesnível do Segmento ST Tipo de estudo: Diagnostic_studies Limite: Animals / Humans Idioma: En Revista: Eur Heart J Acute Cardiovasc Care Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Suécia